Oddo BHF - AFYREN (ALAFY) AFYREN : Unsurprising H1 2024 results – pending continuous production at first plant

Report

Oddo BHF

Jeremy Garnier

AFYREN : Unsurprising H1 2024 results – pending continuous production at first plant

>H1 revenues of € 1.4m, down 30% / EBIT of -€ 3.6m - AFYREN’s H1 2024 results, reported yesterday evening, were broadly in line with our estimates. Revenues dropped by 30% to € 1.4m, with two constituent elements: i/ income from patent licences and ceded to AFYREN NEOXY since December 2018 for € 0.7m (stable) and ii/ service contracts with AFYREN NEOXY, also for € 0.7m (down as a result of the ramp-up of teams on site). Opex is stable (€ 5m), giving EBIT of -€ 3.6m. ...

01/10/2024 1 EN

Underlying

AFYREN

See profile

FR0014005AC9 Euronext Paris France

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Jeremy Garnier

Other Reports on these Companies

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - 10/01/2024

Like Astérix in the album of the same name, Michel Barnier has a cauldron to fill. Two measures to manage this have “leaked” in the press in the last few days: a reduction in the CIR research tax credit and an exceptional tax increase on large companies. We measured the sensitivity to these two measures of the 90 and 80 companies most concerned in our coverage universe. 20 companies have a CIR >5% of their EBIT and 22 companies would see their EPS fall by more than 5% due to the addit...

6h / 13m 6h / 13m 1 EN

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - 01/10/2024

Comme Astérix dans l’album éponyme, Barnier a un chaudron à remplir. Deux mesures pour y parvenir ont « fuité » ces derniers jours dans la presse : rabotage du CIR (Crédit d’impôt Recherche) et hausse « exceptionnelle » de l’impôt des sociétés sur les grands groupes. Nous avons mesuré la sensibilité des 90 et 80 sociétés les plus concernées dans notre univers de couverture à ces deux mesures. 20 sociétés ont un CIR > 5% de leur EBIT et 22 sociétés verraient leurs BPA baisser de plus d...

7h / 1m 7h / 1m 1 FR

Tecan Group AG : Enabling crucial innovation in healthcare

We initiate coverage of Tecan with a TP of CHF 328 and an Outperform rating. As a leading developer and manufacturer of automated laboratory instruments and solutions, Tecan benefits from the rapidly growing trends in the healthcare industry. By focusing on attractive growth segments such as genomics, proteomics and cell & tissue analysis, Tecan should continue to organically outperform the growth of its industry (6.5% revenue CAGR until 2030 vs 3-5% p.a. for the industry). Owing...

5h / 49m 5h / 49m 1 EN

Aurelien Sivignon

Aurelien Sivignon

VusionGroup : Feedback roadshow : Edge Sense est le principal contributeur à la progression des marges à CT et un catalyseur clé pour la trajectoire de croissance à MT

>Principaux messages à retenir - Nous avons organisé un RS à Francfort avec le management de VusionGroup (CFO + IR). Dans un contexte de forte croissance aux USA sous l’impulsion de WMT qui est le premier retailer à déployer Edge Sense, ils entendent démontrer le potentiel commercial de cette nouvelle solution, en rupture avec les ESL classiques, mais aussi son impact positif sur les marges. Par rapport aux ESL traditionnelles, Edge Sense apporte beaucoup plus de fle...

6h / 7m 6h / 7m 1 FR

Oliver Metzger ... (+2)

Oliver Metzger
Thomas Zlowodzki

ODDO BHF Small & MIDCAP MORNING NEWS - 10/01/2024

6h / 13m 6h / 13m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

AFYREN : Unsurprising H1 2024 results – pending continuous production at first plant

ODDO BHF Small & MIDCAP MORNING NEWS - 10/01/2024

ODDO BHF Small & MIDCAP MORNING NEWS - 01/10/2024

Tecan Group AG : Enabling crucial innovation in healthcare

VusionGroup : Feedback roadshow : Edge Sense est le principal contributeur à la progression des marges à CT et un catalyseur clé pour la trajectoire de croissance à MT

ODDO BHF Small & MIDCAP MORNING NEWS - 10/01/2024

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe